Skip to main content
    P

    PharmaCyte Biotech Inc (PMCB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.38
    -0.19 (-3.41%)

    Market Cap: $3.77M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    PharmaCyte Biotech Inc (PMCB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    PharmaCyte Biotech (PMCB) has a market cap of $3.77M. It holds $17.74M more cash than debt, 469.98% of its market cap. Its share count is up 57.98% from a year earlier.

    Total Valuation

    Market Cap$3.77M
    Latest price (Nov 17, 2026)$5.38

    Key Dates

    The next earnings report is expected on Dec 16, 2026, covering the quarter ending Oct 31, 2026.

    Next Earnings DateDec 16, 2026 (expected)
    Last Earnings DateSep 14, 2026
    Fiscal Year EndApril

    Share Statistics

    The share count grew 6.94% a year over 3 years.

    Shares Outstanding565.03K
    Shares Change (YoY)+57.98%
    Share Count Growth (3Y CAGR)+6.94%

    Price Statistics

    The stock is down 64.02% over 52 weeks and trades 26.30% below its 50-day average.

    Beta (1Y)1.93
    52-Week Change-64.02%
    1-Month Change-17.21%
    3-Month Change-46.81%
    6-Month Change-61.32%
    5-Year Change-89.29%
    10-Year Change-99.51%
    Total Return (1Y)-64.02%
    Total Return (3Y CAGR)-48.22%
    Total Return (5Y CAGR)-35.79%
    Return vs SPY (1Y)-73.96%
    Max Drawdown (1Y)-76.79%
    Max Drawdown (3Y)-88.76%
    Sharpe Ratio (1Y)-1.03
    Correlation with SPY (1Y)0.28
    50-Day Average$7.30
    200-Day Average$11.64
    52-Week Range$4.69 to $28.69
    RSI (14 Days)33.6
    Average Volume (20 Days)190.68K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 40.30x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio40.30x
    Quick Ratio40.30x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -58.69% over the last 12 months, against a 5-year average of -1.74%.

    Return on Equity (ROE)-58.69%
    Return on Assets (ROA)-43.98%
    ROE (5Y Average)-1.74%
    ROA (5Y Average)0.80%
    ROIC (5Y Average)-2.11%

    Scores

    PMCB has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Operating Income-$7.01M
    Pretax Income-$16.15M
    Net Income-$16.15M
    Reported EPS (TTM)-$37.22

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 74.94% of the $36.71M in total assets.

    Cash and Equivalents$17.74M
    Total Debt$0
    Net Cash$17.74M
    Net Cash Per Share$31.39
    Working Capital$30.21M
    Shareholder Equity$27.51M
    Book Value Per Share$48.68
    Total Assets$36.71M
    Total Liabilities$6.90M

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$3.94M
    FCF Per Share-$0.37

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Dividends and Yields

    PMCB does not pay a dividend.

    Buyback Yield13.21%
    Shareholder Yield13.21%

    Stock Splits

    The last split was a 1-for-19 reverse split on Nov 13, 2026.

    Last Split DateNov 13, 2026
    Split TypeReverse split
    Split Ratio1:19

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PMCB

    What is PMCB's market cap?

    PharmaCyte Biotech has a market cap of $3.77M.

    How many shares of PMCB are outstanding?

    PharmaCyte Biotech has 565.03K shares outstanding. The count is up 57.98% from a year earlier.

    Does PMCB pay a dividend?

    No. PharmaCyte Biotech does not pay a dividend.

    How much debt does PMCB have?

    PharmaCyte Biotech has $0 of total debt and $17.74M of cash and equivalents, a net cash position of $17.74M.